Serious Event

Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event


Ignite Creation Date: 2025-12-24 @ 12:30 PM
Ignite Modification Date: 2025-12-25 @ 12:09 PM
NCT ID: NCT02408861
Term: DYSPNEA
Organ System: Respiratory, thoracic and mediastinal disorders
Assessment Type: NON_SYSTEMATIC_ASSESSMENT
Source Vocabulary: CTCAE (Unspecified)
Notes: None
Study: NCT02408861
Study Brief: Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG000 0 0 6 View
EG001 0 0 9 View
EG002 0 0 7 View
EG003 0 0 4 View
EG004 1 1 24 View
EG005 0 0 20 View
EG006 0 0 9 View